Development of a population of digital brain phantoms for radionuclide imaging research in Parkinson's disease

开发用于帕金森病放射性核素成像研究的数字脑模型群体

阅读:2

Abstract

PURPOSE: Dopamine transporter (DAT) SPECT is a powerful tool for early diagnosis of Parkinson's disease (PD), while digital phantoms and Monte Carlo (MC) simulations can serve as important research tools. This study aims to develop a novel digital brain phantom population for (99m)Tc-TRODAT-1 ((99m)Tc) and (123)I-ioflupane ((123)I) brain SPECT, and to assess attenuation correction (AC) and scatter correction (SC) in DAT SPECT. METHODS: Striatum, brain background (gray and white matter), and cold regions (skull and cerebrospinal fluid) were segmented from 200 T1 MRI brain images from the PPMI dataset. Striatal binding ratio (SBR) values were retrospectively collected from 200 (123)I and 100 (99m)Tc DAT SPECT patients with suspected PD symptoms from PPMI and a local hospital, respectively. Various activity values were assigned to the randomly paired segmented regions according to a range of SBR values based on the SPECT Visual Interpretation (VI) assessment scheme. The new phantom population was combined with MC simulation tool SIMIND to generate realistic noisy projections. Quantitative accuracy of reconstructed images with attenuation correction (AC) and scatter correction (SC) was assessed. RESULTS: A population of 1000 normal and abnormal PD phantoms was generated for both tracers. Visual comparisons and quantitative analyses demonstrated that simulated data exhibited high similarity to clinical data. Reconstructed images with AC + SC achieved the best quantitative results, followed by AC only, without AC and SC, and SC only. CONCLUSION: The developed digital DAT SPECT phantom population can be served for a wide range of PD applications. Attenuation impacts image quality the most in DAT SPECT, while AC + SC is effective to enhance image quality and quantitative accuracy of DAT SPECT.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。